risperidone has been researched along with Hypochondriacal Neuroses in 3 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 7.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 3.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "Monosymptomatic hypochondriacal psychoses such as delusions of parasitosis are often difficult to treat." | 2.41 | Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. ( Elmer, KB; George, RM; Peterson, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grassi, G | 1 |
| Poli, L | 1 |
| Cantisani, A | 1 |
| Righi, L | 1 |
| Ferrari, G | 1 |
| Pallanti, S | 1 |
| Cetin, M | 1 |
| Ebrinç, S | 1 |
| Ağargün, MY | 1 |
| Yiğit, S | 1 |
| Elmer, KB | 1 |
| George, RM | 1 |
| Peterson, K | 1 |
1 review available for risperidone and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
Topics: Antipsychotic Agents; Humans; Hypochondriasis; Psychotic Disorders; Risperidone | 2000 |
2 other studies available for risperidone and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Fem | 2014 |
Risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
Topics: Adult; Antipsychotic Agents; Drug Administration Schedule; Humans; Hypochondriasis; Male; Paranoid D | 1999 |